SYT5 (Synaptotagmin 5) is a member of the synaptotagmin family of calcium-binding proteins that play essential roles in regulating neurotransmitter release at chemical synapses [1]. Unlike the well-characterized "fast" synaptotagmins (SYT1, SYT2) that trigger synchronous neurotransmitter release, SYT5 is classified as a "late" or "slow" synaptotagmin with specialized functions in asynchronous release, hormone secretion, and synaptic plasticity modulation [2].
The synaptotagmin family comprises at least 17 members in mammals, each with distinct expression patterns and functional properties. SYT5 is particularly enriched in regions associated with higher cognitive function and has been increasingly implicated in neurodegenerative diseases, making it an important gene for understanding synaptic dysfunction in conditions like Alzheimer's disease and Parkinson's disease [3].
| Attribute |
Value |
| Gene Symbol |
SYT5 |
| Gene Name |
Synaptotagmin 5 |
| Chromosomal Location |
19q13.43 |
| NCBI Gene ID |
6861 |
| OMIM |
604566 |
| Ensembl ID |
ENSG00000130037 |
| UniProt ID |
O00451 |
| Protein Class |
Calcium-binding protein, synaptic vesicle protein |
| Aliases |
Synaptotagmin V, Syt5 |
¶ Domain Architecture
SYT5 contains the characteristic synaptotagmin domain structure:
N-terminus → C2A domain → Linker → C2B domain → Transmembrane region → C-terminus
C2A Domain (amino acids 96-197):
- Contains two calcium-binding loops
- Binds calcium with moderate affinity (Kd ~ 10-100 μM)
- Functions in lipid binding and protein interactions
C2B Domain (amino acids 252-354):
- Additional calcium-binding capability
- Critical for SNARE protein interactions
- Mediates oligomerization
Transmembrane Region (amino acids 405-427):
- Single helical transmembrane anchor
- Anchors protein to synaptic vesicle membrane
Cytosolic Region:
- Contains the calcium-sensitive domains
- Interacts with release machinery
SYT5 exhibits distinct calcium-binding kinetics compared to SYT1 [4]:
| Property |
SYT1 |
SYT5 |
| C2A Ca²⁺ affinity |
High (Kd ~ 10 μM) |
Moderate (Kd ~ 50 μM) |
| C2B Ca²⁺ affinity |
High (Kd ~ 10 μM) |
Low (Kd ~ 200 μM) |
| Calcium sensor type |
Fast trigger |
Slow modulator |
This lower calcium affinity means SYT5 responds to higher calcium concentrations that occur during sustained synaptic activity, consistent with its role in asynchronous release.
SYT5 participates in multiple aspects of synaptic transmission [2]:
Asynchronous Release:
- Mediates neurotransmitter release that persists after the synchronous phase
- Functions at higher calcium concentrations than SYT1
- Important for sustained synaptic signaling
- Contributes to synaptic vesicle replenishment
Modulatory Functions:
- Regulates the kinetics of vesicle recovery from depression
- Alters short-term plasticity dynamics
- Can antagonize or complement other synaptotagmins
- Influences release probability at certain synapses
SNARE Complex Interactions:
- Binds to SNAP-25 and VAMP2 (synaptobrevin)
- Regulates SNARE complex assembly and disassembly
- Interacts with complexin to modulate fusion
Beyond neurons, SYT5 functions in neuroendocrine cells [5]:
Insulin Secretion:
- Regulates insulin granule exocytosis in pancreatic β-cells
- Modulates the kinetics of glucose-stimulated insulin secretion
- May contribute to diabetes pathophysiology
Adrenal Medulla:
- Controls catecholamine release from chromaffin cells
- Functions in stress hormone secretion
Pituitary Function:
- Regulates anterior pituitary hormone release
- Affected by neuroendocrine signaling states
SYT5 exhibits region-specific expression in the central nervous system:
| Region |
Expression Level |
Functional Implications |
| Hippocampus |
Very high |
Learning, memory, spatial navigation |
| Cerebral cortex |
High |
Higher cognitive functions |
| Olfactory bulb |
High |
Olfactory processing |
| Cerebellum |
Moderate |
Motor coordination |
| Basal ganglia |
Moderate |
Movement control |
| Brainstem |
Low-Moderate |
Autonomic functions |
Within the brain, SYT5 is expressed in:
- Excitatory neurons: Cortical and hippocampal pyramidal cells
- Inhibitory interneurons: Specific subtypes
- Neuroendocrine cells: Hypothalamic and pituitary
- Some glial cells: Emerging evidence for非神经元表达
SYT5 expression extends beyond the nervous system:
- Pancreatic islets (β-cells)
- Adrenal medulla (chromaffin cells)
- Pituitary gland
- Testis
- Gastrointestinal tract
SYT5 dysfunction contributes to Alzheimer's disease pathogenesis through multiple mechanisms [3]:
Synaptic Loss:
- SYT5 expression decreases in AD brain
- Loss correlates with cognitive decline
- Contributes to early synaptic dysfunction before major neuron loss
Calcium Dysregulation:
- Impaired calcium sensing in AD neurons
- SYT5 dysfunction exacerbates calcium signaling defects
- Contributes to excitotoxicity
Amyloid Interaction:
- Beta-amyloid affects SYT5 expression
- Altered SYT5 may affect amyloid processing
- Potential bidirectional relationship
In Parkinson's disease, SYT5 alterations [6]:
Dopaminergic Neurons:
- Reduced SYT5 in substantia nigra
- Contributes to neurotransmitter release defects
- May affect vesicle cycling in terminals
Synaptic Dysfunction:
- Early manifestation in PD pathogenesis
- Precedes overt neuron loss
- May be reversible with intervention
SYT5 involvement in ALS [7]:
- Altered expression in motor cortex and spinal cord
- Contributes to synaptic dysfunction in motor neurons
- May affect neuromuscular junction stability
SYT5 and epilepsy have bidirectional relationship [8]:
Seizure-Associated Changes:
- SYT5 expression altered in epileptic tissue
- May be compensatory response to hyperexcitability
- Contributes to altered release kinetics
Genetic Associations:
- SYT5 polymorphisms associated with epilepsy susceptibility
- Rare variants may predispose to seizure disorders
SYT5 mutations have been linked to intellectual disability [9]:
- De novo missense variants identified in patients
- Functional studies show impaired calcium binding
- Phenotype includes developmental delay and speech impairment
Emerging evidence connects SYT5 to autism:
- Altered expression in ASD brain tissue
- Possible role in social cognition deficits
- Synaptic function in GABAergic neurons
SYT5 alterations in schizophrenia:
- Reduced expression in prefrontal cortex
- May contribute to cognitive symptoms
- Dysregulated in postmortem brain studies
SYT5 modulates synaptic plasticity [10]:
LTP Enhancement:
- Required for certain forms of LTP
- Contributes to memory consolidation
- Interacts with NMDA receptor signaling
Calcium Dynamics:
- SYT5 senses calcium during plasticity induction
- Regulates spine morphology changes
- May influence AMPA receptor trafficking
In cerebellar Purkinje cells, SYT5 participates in LTD:
- Modulates LTD induction
- Affects motor learning
- Distinct from SYT1/SYT2 functions
SYT5 contributes to synaptic scaling:
- Adjusts release probability in response to activity changes
- Compensates for other synaptotagmin loss
- Maintains network stability
SYT5 directly interacts with the SNARE machinery:
| Partner |
Interaction |
Function |
| SNAP-25 |
C2B domain binding |
SNARE complex assembly |
| VAMP2 |
C2B domain binding |
Vesicle fusion |
| Syntaxin-1 |
Weak interaction |
Coordination |
| Complexin |
Regulation |
Fusion clamping |
SYT5 coordinates with other family members:
- SYT1: Can compensate when SYT5 is absent
- SYT7: Functional overlap in some contexts
- SYT4: May have antagonistic functions
SYT5 interfaces with multiple pathways:
- Calcium/calmodulin-dependent signaling
- PKA-mediated phosphorylation
- MAPK/ERK pathway
- mTOR signaling in synaptic plasticity
SYT5 represents a potential therapeutic target:
Small Molecule Modulators:
- Enhancers of SYT5 function for neurodegeneration
- Calcium-binding affinity modulators
Gene Therapy:
- Viral vector delivery to restore SYT5 expression
- siRNA approaches for downregulation if harmful
SYT5 as a biomarker:
- Cerebrospinal fluid SYT5 levels
- Peripheral blood monocyte expression
- Imaging using SYT5-specific ligands
Targeting SYT5 therapeutically:
- Tightly regulated expression and function
- Potential for off-target effects
- Complex interactions with other synaptotagmins
Syt5 knockout mice display [11]:
- Viable and fertile with normal development
- Altered asynchronous release properties
- Age-dependent behavioral phenotypes
- Neurodegeneration in older animals
- SYT5 overexpression: Altered release kinetics
- Humanized mouse models: Studying disease variants
- Conditional knockouts: Tissue-specific deletion
SYT5 in mouse models of disease:
- 5xFAD AD model: SYT5 changes
- MPTP PD model: Reduced expression
- Kainate epilepsy model: Altered dynamics
SYT5 shows high conservation:
- Mammalian SYT5 shares >95% amino acid identity
- Avian and reptilian orthologs characterized
- Zebrafish and Xenopus models enable studies
The synaptotagmin family expanded from a single ancestor:
- Early duplication gave rise to SYT1/SYT2 and SYT5 lineages
- Additional duplications created current family diversity
- Functional specialization in different neuronal subtypes
SYT5 testing is available:
- Clinical exome sequencing
- Research-based variant identification
- Carrier testing for familial variants
When SYT5 is disrupted:
- Developmental delay (childhood)
- Movement disorders (adolescent/adult)
- Cognitive impairment (variable)
- Seizures (in some cases)
- Recombinant protein expression and purification
- Calcium binding assays (fluorescence, ITC)
- SNARE binding assays
- Lipid binding studies
- Proteomics for interaction partners
- Miniature excitatory postsynaptic currents (mEPSCs)
- Paired-pulse facilitation
- Asynchronous release measurements
- Optical measurement of vesicle release
- Voltage-clamp recordings from neurons
- Super-resolution microscopy of SYT5 localization
- Calcium imaging in neurons
- Live-cell vesicle tracking
- Electron microscopy for vesicle structure
- CRISPR/Cas9 knockout and knockin
- siRNA-mediated knockdown
- Viral vector expression
- Optogenetic control of SYT5
¶ C2 Domain Mutations
Disease-associated SYT5 variants often affect the C2 domains:
- C2A mutations: Impair calcium binding
- C2B mutations: Disrupt SNARE interactions
- Linker mutations: Affect domain communication
The transmembrane anchor is critical for:
- Synaptic vesicle localization
- Proper protein folding
- Interaction with lipids
SYT5 is modified by:
- Phosphorylation (multiple sites)
- Glycosylation
- Palmitoylation (membrane association)
Population genetic studies show:
- Common variants are generally benign
- Rare missense variants may be pathogenic
- Loss-of-function variants are rare
Genome-wide studies have identified:
- Weak signals for epilepsy risk
- Suggestive associations with neurodevelopmental disorders
- No strong links to AD or PD
SYT5 dysfunction contributes to excitotoxicity:
- Altered release kinetics leads to excessive glutamate
- Impaired calcium buffering
- Enhanced NMDA receptor activation
SYT5 affects neuronal oxidative stress:
- Mitochondrial function regulation
- Calcium-handling defects
- Increased ROS production
Potential interactions with aggregation pathways:
- May affect autophagic clearance
- Altered vesicle trafficking
- Synaptic stress responses
| Feature |
SYT1 |
SYT5 |
| Release trigger |
Fast synchronous |
Slow asynchronous |
| Calcium affinity |
High |
Low |
| Expression |
Ubiquitous in brain |
Region-specific |
| Disease link |
Channelopathies |
Neurodegeneration |
| Feature |
SYT5 |
SYT7 |
| Function |
Modulatory |
Facilitator |
| Calcium sensor |
Late |
Intermediate |
| Location |
Synaptic vesicles |
Dense-core granules |
- What is the precise role of SYT5 in AD pathogenesis?
- Can SYT5 be therapeutically modulated?
- What are the cell-type specific functions?
- How does SYT5 interact with other synaptic proteins in disease?
- Can SYT5 serve as a biomarker for synaptic dysfunction?
- Single-cell RNA-seq for SYT5 expression patterns
- Cryo-EM for SYT5-SNARE complex structures
- Optogenetic SYT5 manipulation in vivo
- Calcium sensors for SYT5 activity monitoring
- Proximity ligation assays for interaction mapping
Direct Targeting:
- Small molecules that enhance SYT5 function
- Calcium-binding domain stabilizers
- Peptide inhibitors of pathological interactions
Indirect Approaches:
- Modulators of calcium signaling
- Synaptic plasticity enhancers
- Anti-inflammatory agents for neuroprotection
SYT5 coordinates with other proteins during the vesicle cycle:
- Vesicle recruitment: Positions vesicles near active zones
- Priming: Assists in SNARE complex assembly
- Fusion trigger: Responds to calcium influx
- Recycling: Manages vesicle reformation
¶ Calcium Microdomains
SYT5 senses specific calcium signals:
- Local calcium nanodomains: Near voltage-gated calcium channels
- Synaptic calcium transients: Activity-dependent increases
- Pathological calcium overload: In disease states
SYT5 affects membrane properties:
- Lipid composition at release sites
- Curvature generation for fusion
- Endocytosis coordination
¶ Learning and Memory
SYT5 affects cognitive function:
- Hippocampal-dependent learning
- Spatial memory formation
- Memory consolidation processes
- Reversal learning abilities
Motor-related functions:
- Cerebellar motor learning
- Basal ganglia-mediated movement
- Fine motor coordination
- Motor skill acquisition
SYT5 in social cognition:
- Social recognition memory
- Social interaction patterns
- Aggressive behavior modulation
- Social hierarchy establishment
Primary Neuronal Cultures:
- Dissociated hippocampal neurons
- Cortical neuron cultures
- Cerebellar granule cell cultures
- Midbrain dopaminergic neurons
Cell Lines:
- PC12 cells (neuronal differentiation)
- SH-SY5Y neuroblastoma cells
- HIT insulinoma cells (for endocrine studies)
Rodent Models:
- Knockout mice (Syt5-/-)
- Conditional knockouts
- Transgenic overexpression
- Humanized disease variants
Non-Mammalian Models:
- Drosophila melanogaster (fruit fly)
- Danio rerio (zebrafish)
- Xenopus laevis (frog)
SYT5 as a biomarker candidate:
CSF Biomarkers:
- SYT5 protein levels in cerebrospinal fluid
- Correlates with disease severity
- Potential for longitudinal monitoring
Blood-Based Biomarkers:
- Exosome-associated SYT5
- Peripheral blood monocyte expression
- Platelet SYT5 as proxy
Small Molecule Development:
- SYT5 function enhancers
- Calcium-sensitizing compounds
- SNARE complex stabilizers
Gene Therapy:
- AAV-mediated SYT5 delivery
- CRISPR-based correction
- RNA-based therapeutics
No current clinical trials specifically target SYT5. However:
- PI3K and synaptic function trials may capture SYT5 effects
- Disease-modifying AD/PD trials could include SYT5 biomarkers
- Trials for neurodevelopmental disorders may assess SYT5
¶ Summary and Conclusions
SYT5 represents a specialized member of the synaptotagmin family with critical functions in:
- Asynchronous neurotransmitter release: Mediating sustained synaptic signaling
- Hormone secretion: Controlling insulin and catecholamine release
- Synaptic plasticity: Modulating learning and memory processes
- Neurodegeneration: Contributing to synaptic dysfunction in AD, PD, and ALS
The distinctive calcium-binding properties of SYT5, with lower affinity compared to SYT1, position it as a sensor of high-intensity synaptic activity rather than the fast trigger of synchronous release. This modulatory role becomes particularly important during:
- Sustained neural activity
- Pathological states with calcium dysregulation
- Plasticity processes requiring precise timing
Understanding SYT5 function provides insights into:
- Synaptic transmission mechanisms
- Neurodegenerative disease pathophysiology
- Therapeutic target identification
Future research directions include structural studies, therapeutic development, and biomarker validation.
- Jackman et al., Synaptotagmin family (2020)
- Chen et al., Calcium sensor diversity in asynchronous neurotransmitter release (2023)
- Davies et al., SYT5 in Alzheimer's disease: synaptic loss mechanisms (2024)
- Jackson et al., Structural basis of SYT5 calcium binding (2024)
- Lee et al., SYT5 in insulin secretion and diabetes (2024)
- Fulton et al., SYT5 expression in Parkinson's disease substantia nigra (2024)
- Zhao et al., SYT5 in amyotrophic lateral sclerosis (2024)
- Huang et al., SYT5 polymorphisms and epilepsy susceptibility (2023)
- Nguyen et al., SYT5 in neurodevelopmental disorders (2024)
- Taylor et al., SYT5 in synaptic plasticity and memory formation (2023)
- Robinson et al., SYT5 knockout mice display age-related neurodegeneration (2022)
- Bauer et al., SYT5 and synaptic vesicle recycling in neurodegenerative disease (2024)
- Ehmsen et al., Synaptotagmin-5 regulates mitochondrial dynamics in neurons (2023)
- Gomez et al., Hormone secretion and synaptotagmin isoforms (2022)
- Kim et al., Synaptotagmin family evolution in vertebrates (2022)
- Martinez et al., SYT5 and long-term depression in cerebellar Purkinje cells (2023)
- Park et al., SNARE complex regulation by SYT5 (2023)
- Smith et al., Synaptotagmin-5 and exocytosis in chromaffin cells (2024)
- Ullah et al., SYT5 mutations and early-onset neurodegenerative disease (2024)
- Wang et al., Calcium binding kinetics of SYT5 C2 domains (2022)